Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Alper H.YUKSEL who wrote (29999)	1/9/2000 9:01:00 AM
From: Henry Niman	Read Replies (1) \| Respond to of 32384

Alper, Thanks for the invitation. I suppose that post 30,000 should focus on 3 approved products in 1999, which is rumored to be a Biotech record. In 1999 LGND certainly transitioned into a pharmaceutical company from the approved products point of view. Now all they have to is generate the associated sales. Near term I suspect that psoriasis is the key, in view of the similarities between plaque psoriasis and CTCL. However, positive breast cancer results will be needed to bring in the 3 that many investor are awaiting, which would be a triple digit price for LGND shares. With positive breast cancer results, such a target is doable, and of course the news would generate a Ligand Breakout! and be consistent with the theme in the initial post on this thread.